# Cellebrite DI (CLBT) — Analyst Forecast

CLBT · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/clbt/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 9 | 0 | 0 | 9 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $12.50 | $14.63 | $16.00 | 4 |

Last price $11.38 (as of Oct 15, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Sep 15, 2026 | DA Davidson | Maintained | Buy | $15.00 |
| Aug 14, 2026 | Needham | Maintained | Buy | $12.50 |
| Aug 14, 2026 | DA Davidson | Maintained | Buy | $15.00 |
| Aug 14, 2026 | JP Morgan | Maintained | Overweight | $16.00 |
| Aug 14, 2026 | Lake Street | Maintained | Buy | $15.00 |
| Aug 6, 2026 | DA Davidson | Maintained | Buy | $22.00 |
| May 27, 2026 | DA Davidson | Initiated Coverage | Buy | $20.00 |
| May 15, 2026 | Needham | Maintained | Buy | $15.00 |
| Feb 12, 2026 | Needham | Maintained | Buy | $18.00 |
| Nov 13, 2025 | Needham | Maintained | Buy | $24.00 |
| Nov 13, 2025 | B of A Securities | Maintained | Buy | $25.00 |
| Nov 13, 2025 | Lake Street | Maintained | Buy | $23.00 |
| Nov 13, 2025 | JP Morgan | Maintained | Overweight | $24.00 |
| Sep 24, 2025 | JP Morgan | Maintained | Overweight | $23.00 |
| Aug 15, 2025 | Lake Street | Maintained | Buy | $22.00 |
| Aug 14, 2025 | Needham | Maintained | Buy | $18.00 |
| Jun 6, 2025 | Needham | Maintained | Buy | $24.00 |
| May 14, 2025 | Needham | Maintained | Buy | $24.00 |
| May 12, 2025 | JP Morgan | Maintained | Overweight | $25.00 |
| Apr 2, 2025 | Needham | Maintained | Buy | $28.00 |

## Frequently Asked Questions

### What is the price target for CLBT stock?

The average 12-month analyst price target for Cellebrite DI (CLBT) is $14.63, with a high estimate of $16.00 and a low of $12.50, across 4 analysts.

### Is CLBT a buy, sell, or hold?

Analysts covering Cellebrite DI currently average a Buy rating: 9 buy, 0 hold and 0 sell, from 9 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for CLBT?

The average price target of $14.63 implies 28.51% upside from the last price of $11.38.

### What is the latest analyst rating on CLBT?

On Sep 15, 2026, DA Davidson maintained Cellebrite DI at Buy with a price target of $15.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).